Generating a battery of monoclonal antibodies against native green fluorescent protein for immunostaining, FACS, IP, and ChIP using a unique adjuvant

Monoclonal Antibodies in Immunodiagnosis and Immunotherapy

Volumn 33, Issue 2, 2014, Pages 80-88

  Sanchez, Philip ^a   Daniels, Karla J ^a   Park, Yang Nim ^a   Soll, David R ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND MONOCLONAL ANTIBODY; GREEN FLUORESCENT PROTEIN; IMMUNOLOGICAL ADJUVANT; POLYINOSINIC POLYCYTIDYLIC ACID; CADHERIN; CDH1 PROTEIN, HUMAN; FUNGAL PROTEIN; HYBRID PROTEIN; MONOCLONAL ANTIBODY; PROTEIN BINDING; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EMBRYO; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HYBRIDOMA; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MOUSE; NATIONAL HEALTH ORGANIZATION; NONHUMAN; PRIORITY JOURNAL; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CANDIDA ALBICANS; CHEMISTRY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; PROTEIN DENATURATION; TRANSGENIC ANIMAL; TUMOR CELL LINE; ZEBRA FISH;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; CADHERINS; CANDIDA ALBICANS; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; FUNGAL PROTEINS; GREEN FLUORESCENT PROTEINS; HUMANS; HYBRIDOMAS; MICE; MICE, INBRED BALB C; POLY I-C; PROTEIN BINDING; PROTEIN DENATURATION; RECOMBINANT FUSION PROTEINS; TRANSCRIPTION FACTORS; ZEBRAFISH;

EID: 84899423660     PISSN: None     EISSN: 21679436     Source Type: Journal    
DOI: 10.1089/mab.2013.0089     Document Type: Article

References (33)

1. Shimomura O, Johnson FH, and Saiga Y: Extraction, purification and properties of aequorin, a bioluminescent protein from the luminous hydromedusan, Aequorea. J Cell Compar Physiol 1962;59:223-239.
2. Tsien RY: The green fluorescent protein. Annu Rev Biochem 1998;67:509-544.
3. Cormack BP, Valdivia RH, and Falkow S: FACS-optimized mutants of the green fluorescent protein (GFP). Gene 1996; 173:33-38.
4. Mitra RD, Silva CM, and Youvan DC: Fluorescence resonance energy transfer between blue-emitting and red-shifted excitation derivatives of the green fluorescent protein. Gene 1996;173:13-17.
5. Dubin M, Fuchs J, Graf R, Schubert I, and Nellen W: Dynamics of a novel centromeric histone variant CenH3 reveals the evolutionary ancestral timing of centromere biogenesis. Nucleic Acid Res 2010;38:7526-7537.
6. Rothbauer U, Zolghadr K, Muyldermans S, Schepers A, Cardoso MC, and Leonhardt H: A versatile nanotrap for biochemical and functional studies with fluorescent fusion proteins. Mol Cell Proteomics 2008;7:282-289.
7. Sanchez PJ, McWilliams JA, Haluszczak C, Yagita H, and Kedl RM: Combined TLR/CD40 stimulation mediates potent cellular immunity by regulating dendritic cell expression of CD70 in vivo. J Immunol 2007;178:1564-1572.
8. Llopiz D, Dotor J, Zabaleta A, Lasarte JJ, Prieto J, Borras-Cuesta F, and Sarobe P: Combined immunization with adjuvant molecules poly(I:C) and anti-CD40 plus a tumor antigen has potent prophylactic and therapeutic antitumor effects. Cancer Immunol Immunother 2008;57:19-29.
9. Shulman M, Wilde CD, and Kohler G: A better cell line for making hybridomas secreting specific antibodies. Nature 1978;276:269-270.
10. Abboud CN, DiPersio JF, Brennan JK, and Lichtman MA: Erythropoietic enhancing activity (EEA) secreted by the human cell line, GCT. J Supramol Struct 1980;13:199-209.
11. Park HC, Kim CH, Bae YK, Yeo SY, Kim SH, Hong SK, Shin J, Yoo KW, Hibi M, Hirano T, Miki N, Chitnis AB, and Huh TL: Analysis of upstream elements in the HuC promoter leads to the establishment of transgenic zebrafish with fluorescent neurons. Develop Biol 2000;227: 279-293.
12. Srikantha T, and Soll DR: A white-specific gene in the white-opaque switching-system of Candida albicans. Gene 1993;131:53-60.
13. Park YN, and Morschhauser J: Tetracycline-inducible gene expression and gene deletion in Candida albicans. Eukaryotic Cell 2005;4:1328-1342.
14. Yi S, Sahni N, Daniels KJ, Lu KL, Srikantha T, Huang G, Garnaas AM, and Soll DR: Alternative mating type configurations (a/alpha versus a/a or alpha/alpha) of Candida albicans result in alternative biofilms regulated by different pathways. PLoS Biol 2011;9:e1001117.
15. Borneman AR, Leigh-Bell JA, Yu H, Bertone P, Gerstein M, and Snyder M: Target hub proteins serve as master regulators of development in yeast. Genes Devel 2006;20: 435-448.
16. Srikantha T, Borneman AR, Daniels KJ, Pujol C, Wu W, Seringhaus MR, Gerstein M, Yi S, Snyder M, and Soll DR: TOS9 regulates white-opaque switching in Candida albicans. Eukaryotic Cell 2006;5:1674-1687.
17. Nobile CJ, Fox EP, Nett JE, Sorrells TR, Mitrovich QM, Hernday AD, Tuch BB, Andes DR, and Johnson AD: A recently evolved transcriptional network controls biofilm development in Candida albicans. Cell 2012;148:126-138.
18. Johnson JL, Winterwood N, DeMali KA, and Stipp CS: Tetraspanin CD151 regulates RhoA activation and the dynamic stability of carcinoma cell-cell contacts. J Cell Sci 2009;122:2263-2273.
19. Kam Y, and Quaranta V: Cadherin-bound beta-catenin feeds into the Wnt pathway upon adherens junctions dissociation: evidence for an intersection between beta-catenin pools. PloS One 2009;4:e4580.
20. Slanchev K, Carney TJ, Stemmler MP, Koschorz B, Amsterdam A, Schwarz H, and Hammerschmidt M: The epithelial cell adhesion molecule EpCAM is required for epithelial morphogenesis and integrity during zebrafish epiboly and skin development. PLoS Genet 2009;5: e1000563.
21. Wang B, Wylie FG, Teasdale RD, and Stow JL: Polarized trafficking of E-cadherin is regulated by Rac1 and Cdc42 in Madin-Darby canine kidney cells. Am J Cell Physiol 2005; 288:C1411-1419.
22. Adams CL, Chen YT, Smith SJ, and Nelson WJ: Mechanisms of epithelial cell-cell adhesion and cell compaction revealed by high-resolution tracking of E-cadherin-green fluorescent protein. J Cell Biol 1998;142:1105-1119.
23. Bjorling E, and Uhlen M: Antibodypedia, a portal for sharing antibody and antigen validation data. Mol Cell Proteomic 2008;7:2028-2037.
24. Rhodes KJ, and Trimmer JS: Antibodies as valuable neuroscience research tools versus reagents of mass distraction. J Neurosci 2006;26:8017-8020.
25. Saper CB: An open letter to our readers on the use of antibodies. J Compar Neurol 2005;493:477-478.
26. Guidelines for the use of adjuvants in research, 2013. http:// oacu.od.nih.gov/ARAC/documents/Adjuvants.pdf
27. Stills HF Jr: Adjuvants and antibody production: dispelling the myths associated with Freund's complete and other adjuvants. ILAR J 2005;46:280-293.
28. Oscherwitz J, Hankenson FC, Yu F, and Cease KB: Low-dose intraperitoneal Freund's adjuvant: toxicity and immunogenicity in mice using an immunogen targeting amyloid-beta peptide. Vaccine 2006;24:3018-3025.
29. McCartney S, Vermi W, Gilfillan S, Cella M, Murphy TL, Schreiber RD, Murphy KM, and Colonna M: Distinct and complementary functions of MDA5 and TLR3 in poly(I:C)-mediated activation of mouse NK cells. J Exper Med 2009; 206:2967-2976.
30. Jelinek I, Leonard JN, Price GE, Brown KN, Meyer-Manlapat A, Goldsmith PK, Wang Y, Venzon D, Epstein SL, and Segal DM: TLR3-specific double-stranded RNA oligonucleotide adjuvants induce dendritic cell cross-presentation, CTL responses, and antiviral protection. J Immunol 2011;186:2422-2429.
31. van Kooten C, and Banchereau J: CD40-CD40 ligand. J Leukocyte Biol 2000;67:2-17.
32. Ahonen CL, Doxsee CL, McGurran SM, Riter TR, Wade WF, Barth RJ, Vasilakos JP, Noelle RJ, and Kedl RM: Combined TLR and CD40 triggering induces potent CD8 + T cell expansion with variable dependence on type I IFN. J Exp Med 2004;199:775-784.
33. Kurche JS, Burchill MA, Sanchez PJ, Haluszczak C, and Kedl RM: Comparison of OX40 ligand and CD70 in the promotion of CD4+ T cell responses. J Immunol 2010;185: 2106-2115.